Molecular pathogenesis of diffuse large B-cell lymphoma

Journal of Clinical Oncology

Volumn 23, Issue 26, 2005, Pages 6351-6357

  Lossos, Izidore S ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 2; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV BETA; PROTEIN BCL 2; STAT PROTEIN; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG;

B CELL LYMPHOMA; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CYTOGENETICS; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SOMATIC HYPERMUTATION; SOMATIC MUTATION; COMPARATIVE STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; MALE; MOLECULAR BIOLOGY; MUTATION; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MOLECULAR BIOLOGY; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRANSLOCATION, GENETIC;

EID: 27244445360     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.012     Document Type: Review

References (58)

1. Stevenson F, Sahota S, Zhu D, et al: Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes. Immunol Rev 162:247-259, 1998
2. Lossos IS, Okada CY, Tibshirani R, et al: Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood 95:1797-1803, 2000
3. Ottensmeier CH, Thompsett AR, Zhu D, et al: Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood 91:4292-4299, 1998
4. Uherova P, Ross CW, Schnitzer B, et al: The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma. Am J Clin Pathol 115:582-588, 2001
5. Hans CP, Weisenburger DD, Greiner TC, et al: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275-282, 2004
6. Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511, 2000
7. Rosenwald A, Wright G, Chan WC, et al: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346:1937-1947, 2002
8. Lossos IS, Alizadeh AA, Eisen MB, et al: Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A 97:10209-10213, 2000
9. Huang JZ, Sanger WG, Greiner TC, et al: The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 99:2285-2290, 2002
10. Iqbal J, Sanger WG, Horsman DE, et al: BCL2 translocation defines s unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol 165:159-166, 2004
11. Barrans SL, Evans PA, O'Connor SJ, et al: The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome Clin Cancer Res 9:2133-2139, 2003
12. Davis RE, Brown KD, Siebenlist U, et al: Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 194:1861-1874, 2001
13. Smith PG, Wang F, Wilkinson KN, et al: The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma Blood 105:308-316, 2005
14. Lu X, Nechushtan H, Ding F, et al: Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Blood 105:2924-2932, 2005
15. Akasaka T, Akasaka H, Ueda C, et al: Molecular and clinical features of non-Burkitt's. diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene. J Clin Oncol 18:510-518, 2000
16. Bastard C, Deweindt C, Kerckaert JP, et al: LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 83:2423-2427, 1994
17. Offit K, Lo Coco F, Louie DC, et al: Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large- cell lymphoma. N Engl J Med 331:74-80, 1994
18. Bernardin F, Collyn-d'Hooghe M, Quief S, et al: Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation. Oncogene 14:849-855, 1997
19. Ye BH, Lista F, Lo Coco F, et al: Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262:747-750, 1993
20. Lo Coco F, Ye BH, Lista F, et al: Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 83:1757-1759, 1994
21. Akasaka H, Akasaka T, Kurata M, et al: Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res 60:2335-2341, 2000
22. Chen W, Iida S, Louie DC, et al: Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation. Blood 91:603-607, 1998
23. Cattoretti G, Chang CC, Cechova K, et al: BCL-6 protein is expressed in germinal-center B cells. Blood 86:45-53, 1995
24. Pasqualucci L, Migliazza A, Fracchiolla N, et al: BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A 95:11816-11821, 1998
25. Migliazza A, Martinotti S, Chen W, et al: Freguent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci U S A 92:12520-12524, 1995
26. Lossos IS, Jacobs Y, Cleary ML, et al: Re: Akasaka H, et al. Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res 60:2335-2341, 2000.
27. Cancer Res 61:7363-7364, 2001
28. Lossos IS, Levy R: Mutation analysis of the 5′ noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: Evidence for recurrent mutations and intraclonal heterogeneity. Blood 95:1400-1405, 2000
29. Wang X, Li Z, Naganuma A, et al: Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc Natl Acad Sci U S A 99:15018-15023, 2002
30. Ye BH, Cattoretti G, Shen Q, et al: The BCL-6 proto-oncogene controls germinal-centre formation and Th2- type inflammation Nat Genet 16:161-170, 1997
31. Shaffer AL, Yu X, He Y, et al: BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13:199-212, 2000
32. Phan RT, Dalla-Favera R: The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432:635-639, 2004
33. Koduru PR, Raju K, Vadmal V, et al: Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. Blood 90:4078-4091, 1997
34. Ichikawa A, Kinoshita T, Watanabe T, et al: Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med 337:529-534, 1997
35. Lossos IS, Jones KD, Warnke R, et al: The expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 98:945-951, 2001
36. Houldsworth J, Mathew S, Rao PH, et al: REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 87:25-29, 1996
37. Rao PH, Houldsworth J, Dyomina K, et al: Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 92:234-240, 1998
38. Muschen M, Re D, Jungnickel B, et al: Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J Exp Med 192:1833-1840, 2000
39. Gordon MS, Kanegai CM, Doerr JR, et al: Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc Natl Acad Sci USA 100:4126-4131, 2003
40. Pasqualucci L, Neumeister P, Goossens T. et al: Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412:341-346, 2001
41. Martin A, Bardwell PD, Woo CJ, et al: Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415:802-806, 2002
42. Lossos IS, Levy R, Alizadeh AA: AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Leukemia 18:1775-1779, 2004
43. Monti S, Savage KJ, Kutok JL, et al: Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 105:1851-1861, 2005
44. Lossos IS, Alizadeh AA, Diehn M, et al: Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci U S A 99:8886-8891, 2002
45. Jacob MC, Piccinni MP, Bonnefoix T, et al: T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma: Reactivity toward the malignant clone Blood 75:1154-1162, 1990
46. Lippman SM, Spier CM, Miller TP, et al: Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course Mod Pathol 3:361-367, 1990
47. Miller TP, Lippman SM, Spier CM, et al HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma. J Clin Invest 82:370-372, 1988
48. Rimsza LM, Roberts RA, Miller TP, et al: Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: A follow-up study from the Leukemia and Lymphoma Molecular Profiling Project Blood 103:4251-4258, 2004
49. Bentz M, Barth TF, Bruderlein S, et al: Gain of chromosome arm 9p is characteristic of primary mediastinal B- cell lymphoma (MBL): Comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer 30:393-401, 2001
50. Tsang P, Cesarman E, Chadburn A, et al: Molecular characterization of primary mediastinal B cell lymphoma. Am J Pathol 148:2017-2025, 1996
51. Barth TF, Leithauser F, Joos S, et al: Mediastinal (thymic) large B-cell lymphoma: Where do we stand? Lancet Oncol 3:229-234, 2002
52. Natkunam Y, Lossos IS, Taidi B, et al: Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B cell derivation Blood 105-3979-3986, 2005
53. Rosenwald A, Wright G, Leroy K, et al: Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198:851-862, 2003
54. Savage KJ, Monti S, Kutok JL, et al: The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 102:3871-3879, 2003
55. Copie-Bergman C, Boulland ML, Dehoulle C, et al: Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma. Blood 101:2756-2761, 2003
56. Guiter C, Dusanter-Fourt I, Copie-Bergman C, et al: Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood 104:543-549, 2004
57. Skinnider BF, Elia AJ, Gascoyne RD, et al: Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 99:618-626, 2002
58. Melzner I, Bucur AJ, Bruderlein S, et al: Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 105:2535-2542, 2005